Evidence map›Paper›PMID 35426495›Full record

ArticleAnalytical and bioanalytical chemistry2022

Enhanced ion mobility resolution of Abeta isomers from human brain using high-resolution demultiplexing software.

Soumya Mukherjee, John C Fjeldsted, Colin L Masters, Blaine R Roberts

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Soumya MukherjeeBiomolecular Mass Spectrometry and Proteomics, Utrecht University, Padualaan 8, Utrecht, 3584 CH, The Netherlands.
John C FjeldstedAgilent Technologies, 5301 Stevens Creek Blvd, Santa Clara, CA, 95052, USA.
Colin L MastersFlorey Institute of Neuroscience and Mental Health, University of Melbourne, Victoria, 3010, Melbourne, Australia.
Blaine R RobertsDepartment of Biochemistry, Emory University School of Medicine, 1510 Clifton Rd., Rollins Research Building G223, Atlanta, GA, 30322, USA. blaine.roberts@emory.edu.
Agilent Technologies (United States) · USEmory University · USUniversity of Melbourne · AUUtrecht University · NL

Funding

National Health and Medical Research Council APP1164692
6 · The paper itself

Abstract

Isomerization of aspartic acid (Asp) residues in long-lived proteins is a key feature associated with neurodegenerative proteinopathies such as Alzheimer's disease (AD). Recently, using ultra high-performance liquid chromatography (UHPLC) coupled with drift tube ion mobility mass spectrometry (DTIMS-MS), we documented the extensive Asp isomerization in amyloid-beta (Aβ) peptides depositing in the extracellular cortical plaques (senile plaques) of the AD brain. Aβ

Indexed as

Alzheimer DiseasePlaque, AmyloidAmyloid beta-PeptidesBrainHumansIsomerismProteomicsSoftwareAmyloid beta-PeptidesAlzheimer’s diseaseAβ isomersHigh-resolution demultiplexing (HRdm)Ion mobility separation (IMS)

Identifiers

PMID35426495
OpenAlexW4223893082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.